CMS advised Ypsomed on the deal. Ypsomed, a leading developer and manufacturer of injection and infusion systems for self-medication as well as a proven diabetes specialist,...
Mediq’s Acquisition of DiaExpert
Ypsomed Group’s CHF 122.5 Million Capital Increase
Kellerhals Carrard advised Ypsomed and Zürcher Kantonalbank as Counsel to the Transaction. The 1’000’000 new registered shares of Ypsomed Holding AG were successfully listed on the...